Physician profile
Darryl M Hoffman
NPI 1013995760
$8,758.45
in general payments reported to CMS, 2019-2025
6 companies · $2,319 in 2025
The $2,319 reported for 2025 was more than what a typical Thoracic Surgery (Cardiothoracic Vascular Surgery) provider received nationally (typical 2025 total: $796).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,543 · 2020: $819 · 2021: $76.83 · 2022: $368 · 2023: $299 · 2024: $2,334 · 2025: $2,319.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $2,381 · Food and Beverage: $1,672 · Consulting Fee: $900.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $2,380.79 |
| Food and Beverage | $1,671.54 |
| Consulting Fee | $900.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Atricure, INC. | $3,825.29 | 2019-2025 | Synergy Ablation System |
| Abiomed | $2,382.58 | 2019-2025 | Impella |
| Edwards Lifesciences Corporation | $1,480.20 | 2019-2025 | Inspiris Resilia Aortic Valve |
| Medistim USA, INC. | $734.16 | 2019-2024 | Miraq |
| Lsi Solutions INC | $186.07 | 2019-2021 | |
| Abbott Laboratories | $150.15 | 2023 | Epic |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Darryl Hoffman listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.